Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

被引:0
|
作者
Maria F. Nunez
Armando Sardi
Carol Nieroda
William Jimenez
Michelle Sittig
Ryan MacDonald
Nail Aydin
Vladimir Milovanov
Vadim Gushchin
机构
[1] Institute for Cancer Care at Mercy Medical Center,
来源
关键词
Peritoneal Carcinomatosis; Wound Complication; Port Site; Peritoneal Cancer Index; Complete Cytoreduction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1658 / 1663
页数:5
相关论文
共 50 条
  • [31] Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center
    Rackauskas, Rokas
    Bausys, Augustinas
    Jurgaitis, Jonas
    Paskonis, Marius
    Strupas, Kestutis
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [32] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): 100 Consecutive Patients in an Asian Institution
    Tan, G.
    Teo, M.
    Lim, C.
    Ng, D.
    Tham, C.
    Soo, K.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S105 - S105
  • [33] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Vassos, Nikolaos
    Foertsch, Thomas
    Aladashvili, Archil
    Hohenberger, Werner
    Croner, Roland S.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [34] Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Chokshi, Ravi J.
    Kim, Jin K.
    Patel, Jimmy
    Oliver, Joseph B.
    Mahmoud, Omar
    PLEURA AND PERITONEUM, 2020, 5 (03)
  • [35] Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy
    Cortes-Guiral, Delia
    Mohamed, Faheez
    Glehen, Olivier
    Passot, Guillaume
    EJSO, 2021, 47 (01): : 60 - 64
  • [36] Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    M. Gaillard
    P. Van Eyken
    G. Verswijvel
    K. Van der Speeten
    Indian Journal of Surgical Oncology, 2023, 14 : 240 - 249
  • [37] Factors affecting dietary progression post cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Stibbard, Allysha
    Brown, Morgan
    Pons, Rachel
    Ward, Jessica
    Page, Naomi
    Stefoska-Needham, Anita
    CLINICAL NUTRITION ESPEN, 2024, 63 : 520 - 529
  • [38] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Nikolaos Vassos
    Thomas Förtsch
    Archil Aladashvili
    Werner Hohenberger
    Roland S. Croner
    World Journal of Surgical Oncology, 14
  • [39] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
    Kogler Pamela
    Zitt Matthias
    Kafka-Ritsch Reinhold
    Punter Julia
    Müssigang Peter
    Perathoner Alexander
    Öfner Dietmar
    Journal of Gastrointestinal Surgery, 2018, 22 : 884 - 893
  • [40] RESULTS OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) WITH SIMULTANEOUS COMPLEX RECONSTRUCTION OF THE ABDOMINAL WALL
    Anton Fernandez, Ismael
    Loro Perez, Jorge
    Gonzalez Sanchez, Laura
    Lopez Tomasety, Eudaldo
    Hernandez Hernandez, JuanRamon
    BRITISH JOURNAL OF SURGERY, 2021, 108